DSIJ Mindshare

Amir Shaikh
/ Categories: Trending

BSEs India INX launches Global Access with connectivity to CME Group Exchanges

India INX has announced the launch of a Special Purpose Vehicle (SPV) and 100% wholly owned subsidiary, India INX Global Access IFSC Limited (Global Access) to facilitate access to global exchange markets through a single centralized platform. Global Access is a pioneering venture – the first of its kind from India and IFSC GIFT City to offer access to products traded on international exchanges shall greatly benefit India INX’s members and their clients.

Global Access shall provide its customers a unified single-window interface for trading on CME Group Exchanges, thereby decreasing their overall costs of accessing global markets from IFSC GIFT City. India INX Global Access aims to become the leading financial services provider in IFSC GIFT City in the years ahead by facilitating a centralized access to international financial markets for its customers. This shall provide a competitive and sustainable value proposition for India INX’s members and their clients through efficient access to global market

The key benefits of trading through Global Access are:

* Single-window access to multiple international exchange markets beginning with CME, CBOT, NYMEX, COMEX through Remote Connect.

* Diverse Global Products Portfolio: India INX’s members and their clients can trade on a diverse range of products across multi-asset class – equities, commodities, currencies, fixed income securities – in both cash and derivatives across global exchange markets.

* Efficient Market Access to international exchanges using state-of-the-art technology platforms.

BSE’s India International Exchange (India INX) has maintained its leadership as the No. 1 exchange in IFSC GIFT City accounting for overall market share of 72% approx. and has been growing exponentially since it commenced trading activities on January 16, 2017 with average daily volumes more than USD 700 million.

Previous Article Bharti Airtel gains on expanding tie up with Netflix
Next Article Panacea Biotec inks tripartite agreement for Azacitidine injection in US market
Print
4700 Rate this article:
3.5
Please login or register to post comments.
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR